Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa

November 30, 2021

IAVI’s extensive clinical trial experience will be combined with GreenLight COVID-19 vaccine candidate. Goal is to broaden and accelerate access to messenger RNA (mRNA) COVID-19 vaccines. Phase I trial planned for late Q1 2022. Plan speeds creation of vaccines in Africa, for Africa, and suitable for use in low-income countries globally. NEW YORK – NOVEMBER…

Read more

Scientific Publications

Abortion and its correlates among female fisherfolk along Lake Victoria in Uganda

Read more

Scientific Publications

HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021

Read more

Scientific Publications

Breadth of CD8 T cell mediated inhibition of replication of diverse HIV 1 transmitted founder isolates correlates with the breadth of recognition within a comprehensive HIV 1 Gag Nef Env and Pol potential T cell epitope PTE peptide set

Read more

Features

Enabling the next generation of science leaders

November 10, 2021

Strengthening research and science leadership capacity of African researchers.

Read more

Scientific Publications

Malaria vaccine roller coaster

Read more

Scientific Publications

The importance of partnerships in accelerating HIV vaccine research and development

Read more

Press Releases

IAVI and the Biomedical Advanced Research and Development Authority partner to advance filovirus vaccine candidates

October 27, 2021

NEW YORK – OCTOBER 27, 2021 – IAVI announced today the award of up to US$126 million from the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for…

Read more